Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. VistaGen Therapeutics Inc (VTGN)

  7. VistaGen Therapeutics Inc (VTGN) Financials

VTGN

VistaGen Therapeutics Inc

0.132
-0.0092 (-6.52%)
Upgrade to Real-Time

VistaGen Therapeutics Inc. (VTGN) Fundamentals
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants. The PH94B is a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia; PH10 is an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.
SHARE INFORMATION
Market Cap$ 30,968,905
Shares Outstanding219,326,526
Float205,622,718
Percent Float93.75%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.05
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions237
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months3,396,784
Institutional Holdings Percent34.2%
Institutional Sold Previous 3 Months16,947,673
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months10,000
Insider Holdings Percent0.5
Insider Sold Previous 3 Months-
Insider Shares Owned1,012,302
TRADING INFO
52 Week High$ 1.22
52 Week Low$ 0.08
52 Week High Change$ -87.61
21 Day Moving Average$ 0.1362
21 Day Extended Moving Average$ 0.137167
50 Day Moving Average$ 0.1372
50 Day Extended Moving Average$ 0.141098
200 Day Moving Average$ 0.152291
200 Day Extended Moving Average$ 0.298525
10 Day Average Volume6,375,571
20 Day Average Volume4,141,044
30 Day Average Volume3,302,881
50 Day Average Volume4,640,002
Alpha0.015417
Beta0.9737
Standard Deviation0.377547
R20.019214
7 Day Price Change$ 0.0091
7 Day Percent Change6.89%
21 Day Price Change$ -0.0021
21 Day Percent Change-1.47%
30 Day Price Change$ 0.0003
30 Day Percent Change0.21%
Month to Date Price Change$ -0.0009
Month to Date Percent Change-0.63%
Quarter to Date Price Change$ 0.0165
Quarter to Date Percent Change13.23%
180 Day Price Change$ 0.0052
180 Day Percent Change3.82%
200 Day Price Change$ -0.0208
200 Day Percent Change-12.84%
Year to Date Price Change$ 0.0382
Year to Date Percent Change37.09%

VistaGen Therapeutics Inc. (VTGN) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin-10,033.6%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.40
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio6.10
Leverage Ratio1.40
Quick Ratio5.80
Long Term Debt To Capital0.10
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 8,855,699
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years-0.40
Price To Book1.40
Price To Cash Flow-0.30
PE Low Last 5 Years-19.40
Price to Tangible Book1.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-105.97
Return on Equity-126.59
Return on Capital-119.60

VistaGen Therapeutics Inc. (VTGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOShawn K. Singh
Employees38
Last Audit-
CIK0001411685
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address343 Allerton Avenue,South San Francisco
South San Francisco
South San Francisco, CA 94080
Websitehttps://www.vistagen.com
Facsimile+1 888 482-2602
Telephone+1 650 577-3600
EmailVistaGen@KCSA.com


Your Recent History
NASDAQ
VTGN
VistaGen T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.